Guangzhou Institute of Respiratory Health & State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Guangzhou Laboratory, Guangzhou, People's Republic of China.
BMJ Open Respir Res. 2023 Apr;10(1). doi: 10.1136/bmjresp-2022-001449.
Evidence regarding clinical features and outcomes of individuals with non-obstructive chronic bronchitis (NOCB) remains scarce, especially in never-smokers. We aimed to investigate the clinical features and 1-year outcomes of individuals with NOCB in the Chinese population.
We obtained data on participants in the Early Chronic Obstructive Pulmonary Disease Study who had normal spirometry (post-bronchodilator forced expiratory volume in 1 s/forced vital capacity ≥0.70). NOCB was defined as chronic cough and sputum production for at least 3 months for two consecutive years or more at baseline in participants with normal spirometry. We assessed the differences in demographics, risk factors, lung function, impulse oscillometry, CT imaging and frequency of acute respiratory events between participants with and without NOCB.
NOCB was present in 13.1% (149/1140) of participants with normal spirometry at baseline. Compared with participants without NOCB, those with NOCB had a higher proportion of men and participants with smoke exposure, occupational exposure, family history of respiratory diseases and worse respiratory symptoms (all p<0.05), but there was no significant difference in lung function. Never-smokers with NOCB had higher rates of emphysema than those without NOCB, but airway resistance was similar. Ever-smokers with NOCB had greater airway resistance than those without NOCB, but emphysema rates were similar. During 1-year follow-up, participants with NOCB had a significantly increased risk of acute respiratory events compared with participants who did not have NOCB, after adjustment for confounders (risk ratio 2.10, 95% CI 1.32 to 3.33; p=0.002). These results were robust in never-smokers and ever-smokers.
Never-smokers and ever-smokers with NOCB had more chronic obstructive pulmonary disease-related risk factors, evidence of airway disease and greater risk of acute respiratory events than those without NOCB. Our findings support expanding the criteria defining pre-COPD to include NOCB.
关于非阻塞性慢性支气管炎(NOCB)患者的临床特征和结局的证据仍然很少,尤其是在从不吸烟的人群中。我们旨在研究中国人群中 NOCB 患者的临床特征和 1 年结局。
我们从早期慢性阻塞性肺疾病研究中获取了肺功能正常(支气管扩张剂后 1 秒用力呼气量/用力肺活量≥0.70)的参与者的数据。NOCB 定义为肺功能正常的参与者在基线时有连续 2 年或以上至少 3 个月慢性咳嗽和咳痰。我们评估了有和无 NOCB 的参与者在人口统计学、危险因素、肺功能、脉冲震荡、CT 成像和急性呼吸道事件频率方面的差异。
在基线时有正常肺功能的 1140 名参与者中,13.1%(149/1140)存在 NOCB。与无 NOCB 的参与者相比,有 NOCB 的参与者中男性和有吸烟暴露、职业暴露、呼吸道疾病家族史和更严重的呼吸道症状的比例更高(均 p<0.05),但肺功能无显著差异。有 NOCB 的从不吸烟者比无 NOCB 的从不吸烟者更易发生肺气肿,但气道阻力相似。有 NOCB 的曾吸烟者比无 NOCB 的曾吸烟者气道阻力更大,但肺气肿发生率相似。在 1 年随访期间,调整混杂因素后,有 NOCB 的参与者发生急性呼吸道事件的风险明显高于无 NOCB 的参与者(风险比 2.10,95%CI 1.32 至 3.33;p=0.002)。这些结果在从不吸烟者和曾吸烟者中均稳健。
有 NOCB 的从不吸烟者和曾吸烟者比无 NOCB 的从不吸烟者和曾吸烟者有更多的慢性阻塞性肺疾病相关危险因素、气道疾病证据和更大的急性呼吸道事件风险。我们的研究结果支持将 NOCB 纳入定义 COPD 前期的标准。